BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12792922)

  • 21. Cytogenetic, morphological, and immunophenotypic patterns in Omani patients with de novo acute myeloid leukemia.
    Udayakumar AM; Pathare AV; Al-Kindi S; Khan H; Rehmen JU; Zia F; Al-Ghazaly A; Nusrut N; Khan MI; Wali YA; Al-Lamki Z; Dennison D; Raeburn JA
    Cancer Genet Cytogenet; 2007 Sep; 177(2):89-94. PubMed ID: 17854660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China.
    Zheng J; Wang X; Hu Y; Yang J; Liu J; He Y; Gong Q; Yao J; Li X; Du W; Huang S
    Cytometry B Clin Cytom; 2008 Jan; 74(1):25-9. PubMed ID: 18061959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities.
    Ishizawa S; Slovak ML; Popplewell L; Bedell V; Wrede JE; Carter NH; Snyder DS; Arber DA
    Leukemia; 2003 Jun; 17(6):1091-5. PubMed ID: 12764373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dyshematopoiesis in de novo acute myeloid leukemia: cell biological features and prognostic significance.
    Meckenstock G; Aul C; Hildebrandt B; Heyll A; Germing U; Wehmeier A; Giagounidis A; Suedhoff T; Burk M; Soehngen D; Schneider W
    Leuk Lymphoma; 1998 May; 29(5-6):523-31. PubMed ID: 9643566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blast cells in child and adult AML: comparative study of morphocytochemical, immunological and cytogenetic characteristics.
    Frenkel MA; Tupitsyn NN; Protasova AK; Kadagidze ZG; Konstantinova LN; Fleischman EW
    Br J Haematol; 1994 Aug; 87(4):708-14. PubMed ID: 7986710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytogenetics in acute myeloid leukemia.
    Schoch C; Haferlach T
    Curr Oncol Rep; 2002 Sep; 4(5):390-7. PubMed ID: 12162912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disease features in acute myeloid leukemia with t(8;21)(q22;q22). Influence of age, secondary karyotype abnormalities, CD19 status, and extramedullary leukemia on survival.
    Rege K; Swansbury GJ; Atra AA; Horton C; Min T; Dainton MG; Matutes E; Durosinmi M; Treleaven JG; Powles RL; Catovsky D
    Leuk Lymphoma; 2000 Dec; 40(1-2):67-77. PubMed ID: 11426630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiparameter analysis of acute mixed lineage leukemia: correlation of a B/myeloid immunophenotype and immunoglobulin and T-cell receptor gene rearrangements with the presence of the Philadelphia chromosome translocation in acute leukemias with myeloid morphology.
    Saikevych IA; Kerrigan DP; McConnell TS; Head DR; Appelbaum FR; Willman CL
    Leukemia; 1991 May; 5(5):373-82. PubMed ID: 2033959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphologic, immunologic, and cytogenetic classification of acute myeloid leukemia and myelodysplastic syndrome in childhood: a report from the Childrens Cancer Group.
    Barnard DR; Kalousek DK; Wiersma SR; Lange BJ; Benjamin DR; Arthur DC; Buckley JD; Kobrinsky N; Neudorf S; Sanders J; Miller LP; Shina DC; Hammond GD; Woods WG
    Leukemia; 1996 Jan; 10(1):5-12. PubMed ID: 8558938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes.
    Sorensen PH; Chen CS; Smith FO; Arthur DC; Domer PH; Bernstein ID; Korsmeyer SJ; Hammond GD; Kersey JH
    J Clin Invest; 1994 Jan; 93(1):429-37. PubMed ID: 8282816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new prognostic score for patients with acute myeloid leukemia based on cytogenetics and early blast clearance in trials of the German AML Cooperative Group.
    Haferlach T; Kern W; Schoch C; Schnittger S; Sauerland MC; Heinecke A; Büchner T; Hiddemann W;
    Haematologica; 2004 Apr; 89(4):408-18. PubMed ID: 15075074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements.
    Andersen MK; Johansson B; Larsen SO; Pedersen-Bjergaard J
    Haematologica; 1998 Jun; 83(6):483-8. PubMed ID: 9676019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary chromosomal abnormalities in acute leukemias.
    Johansson B; Mertens F; Mitelman F
    Leukemia; 1994 Jun; 8(6):953-62. PubMed ID: 8207990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute Myeloid Leukemia With Recurrent Cytogenetic Abnormalities.
    Foucar K; Anastasi J
    Am J Clin Pathol; 2015 Jul; 144(1):6-18. PubMed ID: 26071458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML.
    Nishii K; Usui E; Katayama N; Lorenzo F; Nakase K; Kobayashi T; Miwa H; Mizutani M; Tanaka I; Nasu K; Dohy H; Kyo T; Taniwaki M; Ueda T; Kita K; Shiku H
    Leukemia; 2003 Apr; 17(4):731-7. PubMed ID: 12682630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Definition of acute biphenotypic leukemia.
    Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D
    Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New insights into the biology of acute myeloid leukemia and their impact on treatment.
    Hiddemann W; Haferlach T; Schoch C; Behre G; Kohlmann A; Kern W; Feuring-Buske M; Bohlander S
    Verh Dtsch Ges Pathol; 2003; 87():72-8. PubMed ID: 16888897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cytogenetic and clinical study of myeloid leukemia].
    Jiang SH; Shi WY; Liu H; Song GQ; Sun GX; Lu W; Liu DF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):571-3. PubMed ID: 17922430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Classification of AML by morphologic, immunologic and cytogenetic criteria. Review with reference to subtypes in the AML-BFM-87 study].
    Creutzig U; Ritter J; Ludwig WD; Harbott J; Löffler H; Schellong G
    Klin Padiatr; 1993; 205(4):272-80. PubMed ID: 8377447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: results from cancer and leukemia group B study 8461.
    Marcucci G; Mrózek K; Ruppert AS; Archer KJ; Pettenati MJ; Heerema NA; Carroll AJ; Koduru PR; Kolitz JE; Sterling LJ; Edwards CG; Anastasi J; Larson RA; Bloomfield CD
    J Clin Oncol; 2004 Jun; 22(12):2410-8. PubMed ID: 15197203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.